Replies to post #126006 on Vivos Inc (RDGL)

[Roofus]

RDGL needs human trials

RDGL investors need this for sure.
It's the only thing that will drive this stock upward in the long run.

isoPet (alone) without human trials will not enable this stock to break through 10 cents per share, ever (based on current share structure).

isoPet (alone) without human trials would also possibly mean future rounds of dilution and reverse splits.
This is the same thing we've seen in the past 3-4 years from ADMD/RDGL.
Without human trials, we see the same sh*t from RDGL as we've seen in the recent past.

But if we see human trails, we're millionaires.

It's a gamble, but could pay off big time. It all hinges on human trials.